Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fahn

Showing results (281-290 of 407) with videos related to

Pageof 41
Sort By:
Neurology|August 1, 1979
The role of bromocriptine in the treatment of parkinsonismS Fahn, L J Cote, S R Snider, et al.
Neurology|August 1, 1981
Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington diseaseR E Burke, S Fahn, R Mayeux, et al.
Neurology|February 1, 1992
Motor blocks in Parkinson's diseaseN Giladi, D McMahon, S Przedborski, et al.
Archives of Neurology|March 1, 1988
An estimate of the prevalence of dementia in idiopathic Parkinson's diseaseR Mayeux, Y Stern, R Rosenstein, et al.
Archives of Neurology|May 1, 2001
The DYT1 mutation and nonfamilial primary torsion dystoniaS B Bressman, S Fahn, L J Ozelius, et al.
Neurology|February 1, 1996
Cutaneous electromyographic silent period findings in brachial dystoniaS L Pullman, B Ford, B Elibol, et al.
Brain Research Bulletin|July 1, 1992
Implantation of genetically modified mesencephalic fetal cells into the rat striatumS M Zhu, K Kujirai, A Dollison, et al.
ASAIO Transactions|October 1, 1988
Intracerebroventricular infusion of dopamine and its agonists in rodents and primates. An experimental approach to the treatment of Parkinson's diseaseJ Garcia de Yebenes, S Fahn, M A Mena, et al.
Advances in Neurology|January 1, 1990
Intracerebroventricular infusion of (+)-4-propyl-9-hydroxy-naphthoxacine in monkeys with MPTP-induced akinesiaJ G de Yébenes, S Fahn, R Goodman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Neurotoxicity of levodopa on catecholamine-rich neuronsM A Mena, B Pardo, M J Casarejos, et al.
Pageof 41

Showing results (281-290 of 407) with videos related to

Sort By:
Pageof 41
Neurology|August 1, 1979
The role of bromocriptine in the treatment of parkinsonismS Fahn, L J Cote, S R Snider, et al.
Neurology|August 1, 1981
Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington diseaseR E Burke, S Fahn, R Mayeux, et al.
Neurology|February 1, 1992
Motor blocks in Parkinson's diseaseN Giladi, D McMahon, S Przedborski, et al.
Archives of Neurology|March 1, 1988
An estimate of the prevalence of dementia in idiopathic Parkinson's diseaseR Mayeux, Y Stern, R Rosenstein, et al.
Archives of Neurology|May 1, 2001
The DYT1 mutation and nonfamilial primary torsion dystoniaS B Bressman, S Fahn, L J Ozelius, et al.
Neurology|February 1, 1996
Cutaneous electromyographic silent period findings in brachial dystoniaS L Pullman, B Ford, B Elibol, et al.
Brain Research Bulletin|July 1, 1992
Implantation of genetically modified mesencephalic fetal cells into the rat striatumS M Zhu, K Kujirai, A Dollison, et al.
ASAIO Transactions|October 1, 1988
Intracerebroventricular infusion of dopamine and its agonists in rodents and primates. An experimental approach to the treatment of Parkinson's diseaseJ Garcia de Yebenes, S Fahn, M A Mena, et al.
Advances in Neurology|January 1, 1990
Intracerebroventricular infusion of (+)-4-propyl-9-hydroxy-naphthoxacine in monkeys with MPTP-induced akinesiaJ G de Yébenes, S Fahn, R Goodman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Neurotoxicity of levodopa on catecholamine-rich neuronsM A Mena, B Pardo, M J Casarejos, et al.
Pageof 41